Status:

UNKNOWN

Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

Lead Sponsor:

University Hospital, Essen

Conditions:

Pediatric Kidney Disease

Eligibility:

All Genders

8-18 years

Phase:

PHASE3

Brief Summary

Recently, a new prolonged-release tablet version of tacrolimus (Envarsus®) using the so-called MeltDose™ (US Patent No. 7,217,431) drug-delivery technology has been approved as immunosuppressive medic...

Eligibility Criteria

Inclusion

  • caucasian paediatric kidney transplant recipients (single-organ recipients)
  • aged ≥ 8 years but ≤ 18 years who are under tacrolimus (Prograf®) therapy and who are able to swallow tablets with a minimum dose of 0.75 mg / day Envarsus®
  • not less than 6 months after transplantation
  • stable kidney function (delta eGFR \< 10 ml/min/1.73 m2 (CKID formula) over the last 3 months)
  • women of childbearing potential and women without childbearing potential
  • patient/parents/legal guardian(s) must be capable of understanding purpose and risks of the study
  • signed informed consent obtained by patient and parents/legal guardians

Exclusion

  • coefficient of variation of tacrolimus trough levels \> 0.35 over the previous 6 months
  • pregnancy/breast feeding
  • instable kidney function
  • hypersensitivity to any of the components of the medications used
  • not eligible for any reason according to the investigator's valuation
  • known positive HIV-1 or HCV test
  • participation in another clinical trial (other investigational drugs or devices at the time of enrolment or within 30 days prior to enrolment)

Key Trial Info

Start Date :

April 25 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06057545

Start Date

April 25 2023

End Date

March 1 2025

Last Update

September 28 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University Hospital Cologne, Pediatrics

Cologne, Germany

2

University Hospital of Essen, Pediatrics II

Essen, Germany

3

University Hospital of Hamburg-Eppendorf

Hamburg, Germany

4

University Hospital of Heidelberg

Heidelberg, Germany